Show simple item record

dc.contributor.advisorde Kock, M.
dc.contributor.advisorVandevoorde, C.
dc.contributor.authorEngelbrecht, Monique
dc.date.accessioned2021-03-23T09:04:52Z
dc.date.available2021-03-23T09:04:52Z
dc.date.issued2020
dc.identifier.urihttp://hdl.handle.net/11394/8012
dc.descriptionPhilosophiae Doctor - PhDen_US
dc.description.abstractEpidemiological studies have highlighted that leukaemia can be considered as the most prominent malignancy after radiation exposure during childhood. The lifetime risk on radiation-induced leukaemia for a given dose is 3 – 5 times higher for children compared to adults. The high risk at a young age is related to the elevated sensitivity of the red bone marrow where haematopoietic stem and progenitor cells (HSPCs) are located. HSPCs self-renewal capacity and long-life span increase their susceptibility to DNA damage accumulation, making them a major target of radiation-induced carcinogenesis. Proton beam therapy (PBT) is increasingly used to treat paediatric brain tumours due to its dose sparing properties compared to conventional X-ray based radiotherapy.en_US
dc.language.isoenen_US
dc.publisherUniversity of the Western Capeen_US
dc.subjectRadiationen_US
dc.subjectSouth Africaen_US
dc.subjectLeukaemiaen_US
dc.subjectCD34+ cellsen_US
dc.subjectRadiotherapyen_US
dc.titleRadiation-induced Leukaemia in South Africa: Response of lymphocytes and cd34+ cells to different radiation qualitiesen_US
dc.rights.holderUniversity of the Western Capeen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record